-
30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease
Mar 10, 2025, 14:00 PM -
Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023
Mar 10, 2025, 14:00 PM -
A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension
Mar 10, 2025, 14:00 PM -
The Impact of Glucocorticoid (GC) Dose on Clinical Outcomes in Congenital Adrenal Hyperplasia (CAH): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges
Mar 10, 2025, 14:00 PM -
Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data
Mar 10, 2025, 14:00 PM -
Implementation of New Real-World Data Quality Frameworks and Initiatives to Address Challenges in Oncology Electronic Health Record (EHR)-Derived Databases for Research
Mar 10, 2025, 14:00 PM -
Mapping the NEI-VFQ-25 to the EQ-5D-Y-3L and CHU-9D among High School Students with Myopia in China
Mar 10, 2025, 14:00 PM -
Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)
Mar 10, 2025, 14:00 PM -
National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data
Mar 10, 2025, 14:00 PM -
Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study
Mar 10, 2025, 14:00 PM -
A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices
Mar 10, 2025, 14:00 PM -
Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis
Mar 10, 2025, 14:00 PM -
Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy & Testing Policies?
Mar 10, 2025, 14:00 PM -
Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies
Mar 10, 2025, 14:00 PM -
A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension
Mar 10, 2025, 14:00 PM -
Demonstration of a Population-Level Biomarker Testing Economic Evaluation Tool for Oncology Interventions
Mar 10, 2025, 14:00 PM -
Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM